NSI-189 (NEURALIN) – Nootropic-an antidepressant of the new generation is able to completely get rid of any depression where other drugs have been powerless. This Nootropic is funded by several major research organizations in the United States was created specifically to combat all types of depression and their consequences in the form of cognitive impairment.
This Nootropic stimulates growth of new neurons in the brain, thus restoring the learning ability and memory function, and its antidepressant effect will return a good mood and make you much stress-resistant. According to numerous reviews, this Nootropic has helped many people, returning them to health and joy of daily life, as well as markedly improving their capacity for learning and remembering new information.
the Minimum applied dosage is 20 mg per day, the average recommended dosage is 40-60mg in the morning and 80-120mg in the treatment of major depressive disorder and cognitive impairments. It is recommended to start with smaller doses and gradually increase to achieve a personal optimal level.Side effects and contraindications
NSI-189 is sufficiently explored and is under clinical trials as most of the nootropics has recommendations for use. It was found that NSI-189 is a safe and well-tolerated without any serious side effects.
Not recommended to take NSI-189 in conjunction with other nootropics and antidepressants, as their cooperation was not yet sufficiently studied.
combined with the Nootropic group racetams except coluracetam and fasoracetam. Simultaneous treatment with piracetam and other Nootropic group racetams may lead to increased side effects and strong headaches.